Metabolic Disorders Among HIV-Infected Patients Treated With Protease Inhibitors: A Review
- 1 October 2000
- journal article
- review article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 25, S4-S11
- https://doi.org/10.1097/00126334-200010001-00002
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Buffalo Hump in a Patient with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1998
- Lipodystrophy Associated with an HIV-Protease InhibitorNew England Journal of Medicine, 1998
- Antiretroviral Therapy for HIV Infection in 1998JAMA, 1998
- A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitorsAIDS, 1998
- Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapyThe Lancet, 1998
- Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral TherapyNew England Journal of Medicine, 1997
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997
- HIV-1 protease inhibitors. A review for cliniciansJAMA, 1997
- Therapy for Human Immunodeficiency Virus Infection — What Have We Learned?New England Journal of Medicine, 1996
- Protease Inhibitors for HIV InfectionAnnals of Internal Medicine, 1996